[4] [2] Clinical trials have demonstrated substantial reductions in hemoglobin A1c (up to 2.5%) and body weight (approximately 15-22.5% depending on dose in the SURMOUNT-1 trial), making it a significant advancement in metabolic disease treatment
What matters is total daily calorie intake and macronutrient balance, not meal frequency
For use as a treatment for type 2 diabetes, the injections are administered as part of a plan that also includes diet and exercise as a means to manage the blood sugar levels of the patient
For thyroid patients, this $99 add-on test (available after your first month) reveals genetic predispositions to weight gain and personalizes your treatment protocol with 150+ insights
While this price cut addressed Access and Affordability the question here is about the Awareness
Chen S, Yin L, Xu Z, An FM, Liu AR, Wang Y, et al